MCID: DNG003
MIFTS: 58

Dengue Disease malady

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Dengue Disease

About this section

Aliases & Descriptions for Dengue Disease:

Name: Dengue Disease 34 11 13
Dengue Fever 11 47 2 13 67
Dengue 49 37 38
Dengue Shock Syndrome 47 67
Df 47 2
Philippine Hemorrhagic Fever 47
Singapore Hemorrhagic Fever 47
Dengue Hemorrhagic Fever 47
 
Dengue Virus Infection 47
Thai Hemorrhagic Fever 47
Hemorrhagic Dengue 47
Classical Dengue 11
Breakbone Fever 11
Classic Dengue 11
Severe Dengue 67

Classifications:



External Ids:

Disease Ontology11 DOID:12205
ICD1029 A90
ICD9CM31 061
MeSH38 D003715
NCIt44 C34528

Summaries for Dengue Disease

About this section
MedlinePlus:37 Dengue is an infection caused by a virus. you can get it if an infected mosquito bites you. dengue does not spread from person to person. it is common in warm, wet areas of the world. outbreaks occur in the rainy season. dengue is rare in the united states. symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. in some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from your nose, gums, or under your skin. it can also become dengue shock syndrome, which causes massive bleeding and shock. these forms of dengue are life-threatening. there is no specific treatment. most people with dengue recover within 2 weeks. until then, drinking lots of fluids, resting and taking non-aspirin fever-reducing medicines might help. people with the more severe forms of dengue usually need to go to the hospital and get fluids. to lower your risk when traveling to areas where dengue is found wear insect repellent with deet wear clothes that cover your arms, legs and feet close unscreened doors and windows nih: national institute of allergy and infectious diseases

MalaCards based summary: Dengue Disease, also known as dengue fever, is related to dengue fever, protection against and dengue hemorrhagic fever, and has symptoms including fever, severe headache and severe pain behind the eyes. An important gene associated with Dengue Disease is CD209 (CD209 Molecule), and among its related pathways are LDL Oxidation in Atherogenesis and CD209 (DC-SIGN) signaling. Affiliated tissues include eye, skin and bone, and related mouse phenotypes are hematopoietic system and immune system.

Disease Ontology:11 A viral infectious disease that results in infection, has material basis in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.

Related Diseases for Dengue Disease

About this section

Diseases related to Dengue Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 52)
idRelated DiseaseScoreTop Affiliating Genes
1dengue fever, protection against12.3
2dengue hemorrhagic fever10.8
3dengue shock syndrome10.8
4asymptomatic dengue10.8
5overnutrition10.6ICAM1, VCAM1
6lymphomatoid papulosis10.6ICAM1, VCAM1
7marginal corneal ulcer10.6ICAM1, VCAM1
8parasitic helminthiasis infectious disease10.6CD40LG, ICAM1
9rhizomelic pseudopolyarthritis10.6ICAM1, VCAM1
10ganglioneuroblastoma10.5CD209, CD40LG
11posterolateral myocardial infarction10.5ICAM1, VCAM1
12crater-like holes of optic disc10.5CD209, CD40LG
13gonococcal bursitis10.5CD40LG, MBL2
14intracranial primitive neuroectodermal tumor10.5ICAM1, VCAM1
15ainhum10.5CD40LG, RAF1
16indian tick typhus10.5CCL5, CD40LG
17vestibule of mouth cancer10.4CD40LG, ICAM1
18spastic paraplegia-paget disease of bone syndrome10.4ICAM1, VCAM1
19splenic infarction10.4CD40LG, THPO
20prostatic hypertrophy10.4CD40LG, THPO
21otof-related deafness10.4PTPN11, RAF1
22hodgkin's lymphoma, mixed cellularity10.4CD40LG, ICAM1, VCAM1
23inner ear disease10.4CCL5, CD209, MBL2
24platelet storage pool deficiency10.4CD40LG, IL11, THPO
25human monocytic ehrlichiosis10.4CCL5, CD209, CD40LG
26pterygium colli mental retardation digital anomalies10.4PTPN11, RAF1
27iron metabolism disease10.3CCL5, ICAM1, VCAM1
28hemolytic-uremic syndrome10.3CD40LG, PIK3C2A
29rad51c-related fanconi anemia10.3PTPN11, RAF1
30retroperitoneal fibrosis10.3CCL5, CD40LG, THPO
31laryngeal tuberculosis10.3CCL5, CD40LG, ICAM1
32esophagus squamous cell papilloma10.3CCL5, CD209, CD40LG
33acute dacryocystitis10.3ICAM1, VCAM1
34arteriolosclerosis10.3ICAM1, VCAM1
35basaloid squamous cell carcinoma10.3CCL5, CD40LG, ICAM1
36chromophobe adenoma10.3FCGR1A, ICAM1, VCAM1
37neurotic disorder10.3CD40LG, PTPN11, THPO
38congenital nystagmus10.2CD40LG, PIK3C2A
39chromoblastomycosis10.2CD40LG, ICAM1
40japanese encephalitis10.2CD40LG, RAF1
41gemistocytic astrocytoma10.1CCL5, CD40LG, ICAM1, VCAM1
42sacral spinal canal and spinal cord meningioma10.1CD40LG, ICAM1, PIK3C2A
43legionaire disease10.1CD40LG, PIK3C2A
44west nile fever10.0ICAM1, VCAM1
45rheumatoid arthritis9.9CCL5, CD40LG, ICAM1, IL11, VCAM1
46asthma9.8CCL5, CD40LG, ICAM1, IL11, VCAM1
47taylor's syndrome9.8CCL5, CD40LG, SENP8
48endotheliitis9.7
49systemic lupus erythematosus9.5CCL5, CD40LG, FCGR1A, ICAM1, MBL2, VCAM1
50thrombocytopenia9.5

Graphical network of the top 20 diseases related to Dengue Disease:



Diseases related to dengue disease

Symptoms for Dengue Disease

About this section

Symptoms:

 11 (show all 7)
  • fever
  • severe headache
  • severe pain behind the eyes
  • joint pain
  • muscle
  • rash
  • mild bleeding

UMLS symptoms related to Dengue Disease:


pruritus

Drugs & Therapeutics for Dengue Disease

About this section

Drugs for Dengue Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 59)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
KetotifenapprovedPhase 42234580-14-8, 34580-13-73827
Synonyms:
10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1)
116655-74-4
34580-13-7
4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one
4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one
4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one
4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one
4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one
AB00053575
AC-15945
AC1L1GSZ
AKOS000541268
Alaway (TN)
BAS 00444483
BIDD:GT0509
BPBio1_000575
BRD-K28936863-051-05-8
BRN 3983897
BSPBio_000521
BSPBio_002964
C19H19NOS
CAS-34580-14-8
CHEBI:112957
CHEMBL534
CID3827
D08105
DB00920
DivK1c_000111
EINECS 252-099-7
HC 20-511
HMS2090F16
HSDB 7283
IDI1_000111
KBio1_000111
KBio2_000906
KBio2_003474
KBio2_006042
KBio3_002184
KBioGR_001289
KBioSS_000906
Ketotifen (INN)
Ketotifen Fumarate
 
Ketotifen [INN:BAN]
Ketotifene
Ketotifene [INN-French]
Ketotifene fumarate
Ketotifeno
Ketotifeno [INN-Spanish]
Ketotifenum
Ketotifenum [INN-Latin]
Ketotifin
Ketotiphen
Ketotiphene
L000753
LS-33820
Lopac-K-2628
Lopac0_000706
MolPort-001-933-278
NCGC00015580-01
NCGC00015580-02
NCGC00015580-03
NCGC00015580-09
NCGC00022572-02
NCGC00022572-04
NCGC00022572-05
NINDS_000111
Oprea1_335550
Oprea1_553550
Prestwick0_000371
Prestwick1_000371
Prestwick2_000371
Prestwick3_000371
SPBio_001275
SPBio_002442
STK048448
STOCK1S-14132
Spectrum2_001198
Spectrum3_001382
Spectrum4_000805
Spectrum5_001395
Spectrum_000426
Tocris-0784
UNII-X49220T18G
Zaditor
ketotifen
2
HistamineapprovedPhase 4103475614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
3
Histamine PhosphateapprovedPhase 4103351-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
4VaccinesPhase 4, Phase 3, Phase 1, Phase 26428
5Neurotransmitter AgentsPhase 417734
6Anti-Allergic AgentsPhase 41490
7Dermatologic AgentsPhase 45674
8AntipruriticsPhase 4864
9Histamine H1 AntagonistsPhase 4782
10Histamine AntagonistsPhase 4946
11
Ivermectinapproved, vet_approvedPhase 2, Phase 35770288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
 
HMS2089M09
I 8898
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
12Antiparasitic AgentsPhase 2, Phase 3, Phase 12127
13Anti-Infective AgentsPhase 2, Phase 3, Phase 121402
14Protective AgentsPhase 37190
15Pharmaceutical SolutionsPhase 3, Phase 2, Phase 17793
16Insect RepellentsPhase 33
17DEETPhase 32
18Heptavalent Pneumococcal Conjugate VaccinePhase 3, Phase 2454
19
RibavirinapprovedPhase 298436791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
NSC 163039
 
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
20
Hydrocortisoneapproved, vet_approvedPhase 264050-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
21
chloroquineapproved, vet_approvedPhase 1, Phase 214754-05-72719
Synonyms:
( -)-Chloroquine
(+)-Chloroquine
(-)-Chloroquine
(R)-(-)-Chloroquine
3377 RP opalate
3545-67-3
50-63-5
54-05-7
56598-66-4
58175-86-3
58175-87-4
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
AB00053436
AC1L1EB8
AC1Q2ZA7
AC1Q2ZA8
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
BPBio1_000655
BRD-A91699651-065-01-1
BRN 0482809
BSPBio_000595
BSPBio_002001
Bemaco
Bemaphate
Bemasulph
Benaquin
Bipiquin
C07625
C18H26ClN3
CCRIS 3439
CHEBI:3638
CHEMBL76
CID2719
CQ
CU-01000012392-2
Capquin
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine Bis-Phosphoric Acid
Chloroquine Phosphate
Chloroquine [USAN:INN:BAN]
Chloroquine phosphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
D02366
DB00608
Dawaquin
Delagil
Dichinalex
DivK1c_000404
EINECS 200-191-2
Elestol
Gontochin
Gontochin phosphate
HMS2090O03
HSDB 3029
Heliopar
Hydroxychloroquine Sulfate
IDI1_000404
Imagon
 
Ipsen 225
Iroquine
KBio1_000404
KBio2_000592
KBio2_003160
KBio2_005728
KBio3_001221
KBioGR_000778
KBioSS_000592
Khingamin
Klorokin
LS-141726
Lapaquin
Lopac0_000296
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
MolMap_000009
MolPort-001-783-623
N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine
N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine
NCGC00015256-04
NCGC00162120-01
NCI60_000894
NINDS_000404
NSC 187208
NSC14050
NSC187208
Neochin
Nivachine
Nivaquine
Nivaquine B
Pfizerquine
Plaquenil
Prestwick0_000548
Prestwick1_000548
Prestwick2_000548
Prestwick3_000548
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
RP 3377
RP-3377
Resochen
Resochin
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
SMP2_000034
SN 6718
SN-7618
SPBio_000174
SPBio_002516
ST 21
ST 21 (pharmaceutical)
Sanoquin
Silbesan
Siragan
Solprina
Sopaquin
Spectrum2_000127
Spectrum3_000341
Spectrum4_000279
Spectrum5_000707
Spectrum_000132
Tanakan
Tanakene
Tresochin
Trochin
UNII-886U3H6UFF
W 7618
WIN 244
WLN: T66 BNJ EMY1&3N2&2 IG
chloroquine
nchembio.215-comp4
nchembio.368-comp8
nchembio.87-comp17
{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
22
Neomycinapproved, vet_approvedPhase 1, Phase 2481404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
 
Framygen
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
23Antiviral AgentsPhase 29732
24Hydrocortisone acetatePhase 2640
25Peripheral Nervous System AgentsPhase 1, Phase 222776
26Hydrocortisone 17-butyrate 21-propionatePhase 2640
27Cortisol succinatePhase 2640
28AntimetabolitesPhase 211774
29Chloroquine diphosphatePhase 1, Phase 214750-63-5
30Analgesics, Non-NarcoticPhase 1, Phase 26260
31AnalgesicsPhase 1, Phase 211287
32Anti-Inflammatory AgentsPhase 1, Phase 210355
33AnthelminticsPhase 1, Phase 2431
34Antirheumatic AgentsPhase 1, Phase 210627
35Anti-Inflammatory Agents, Non-SteroidalPhase 1, Phase 24295
36Antiprotozoal AgentsPhase 1, Phase 21986
37AntimalarialsPhase 1, Phase 21216
38HemostaticsPhase 21359
39CoagulantsPhase 21428
40AntibodiesPhase 1, Phase 26045
41ImmunoglobulinsPhase 1, Phase 26045
42
Aluminum hydroxideapprovedPhase 120121645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
43Adjuvants, ImmunologicPhase 12484
44Anti-Ulcer AgentsPhase 11767
45Gastrointestinal AgentsPhase 18109
46AntacidsPhase 11767
47Aluminum sulfatePhase 187
48PapayaNutraceuticalPhase 116
49
Acetaminophenapproved978103-90-21983
Synonyms:
4'-Hydroxyacetanilide
4'-hydroxyacetanilide
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
4-acetamidophenol
A-Per
A.F. Anacin
AC1Q1KYJ
AC1Q1KYK
APAP
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-Tap
Acenol
Acephen
Acertol
Aceta Elixir
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetaminofen
Acetaminophen
Acetaminophen Uniserts
Acetamol
Acetavance
Acetofen
Actamin
Actamin Extra
Actamin Super
Actifed Plus
Actimol
Actimol Chewable Tablets
Actimol Children'S Suspension
Actimol Infants' Suspension
Actimol Junior Strength Caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen Max
Anacin
Anacin 3
Anacin-3
Anacin-3 Extra Strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-Algos
Antidol
Anuphen
Apacet
Apacet Capsules
Apacet Elixir
Apacet Extra Strength Caplets
Apacet Extra Strength Tablets
Apacet Regular Strength Tablets
Apadon
Apamid
Apamide
Apitrelal
Apo-Acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin Free Anacin Maximum Strength Caplets
Aspirin Free Anacin Maximum Strength Gel Caplets
Aspirin Free Anacin Maximum Strength Tablets
Aspirin-Free Anacin
Aspirin-Free Excedrin Caplets
Asplin
Atasol
Atasol Caplets
Atasol Drops
Atasol Forte Caplets
Atasol Forte Tablets
Atasol Oral Solution
Atasol Tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap Hc
Banesin
Bayer Select
Bayer Select Allergy-Sinus
Bayer Select Head Cold
Bayer Select Headache Pain
Bayer Select Maximum Strength Headache Pain Relief Formula
Bayer Select Menstrual Multi-Symptom
Bayer Select Sinus Pain Relief
Ben-u-ron
Benmyo
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
CCRIS 3
CHEBI:46195
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with Codeine
Captin
Causalon
Cefalex
Cetadol
Children'S Acetaminophen Elixir Drops
Children'S Acetaminophen Oral Solution
Children'S Tylenol Chewable
Claradol Codeine
Clixodyne
Co-Gesic
Cod-Acamol Forte
Codabrol
Codalgin
Codapane
Codicet
Codisal
Codisal Forte
Codoliprane
Codral Pain Relief
Cofamol
Conacetol
Contac Cough & Sore Throat Formula
Contra-Schmerz P
Coricidin
Coricidin D
Coricidin Sinus
Cosutone
Croix Blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril Extra-Strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
Dhc Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dol-Stop
Dolcor
Dolefin
Dolegrippin
Dolene AP-65
Dolene Ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol Forte
Dolorstop
Dolotec
Dolprone
Dorocoff
Dresan
Dristan Cold No Drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne Dhc
Durapan
Dymadon
Dymadon Co
Dymadon Forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-Plus
Eu-Med
Excedrin
Excedrin Caplets
Excedrin Extra Strength Caplets
Excipain
Exdol
Exdol Strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall Junior Strength
Feverall Sprinkle Caps Junior Strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap Children'S Elixir
Genapap Children'S Tablets
Genapap Extra Strength Caplets
Genapap Extra Strength Tablets
Genapap Regular Strength Tablets
Genebs
Genebs Extra Strength Caplets
Genebs Regular Strength Tablets
Genebs X-Tra
Geralgine-P
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hy-Phen
Hycomine Compound
Hydrocet
Ildamol
Inalgex
Infadrops
Infants' Feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior Disprol
KBio1_000660
Kataprin
Kinder Finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic Co
Liquiprin
Liquiprin Children'S Elixir
Liquiprin Infants" Drops
Lonarid
Lonarid Mono
Lorcet-Hd
Lortab
Lupocet
Lyteca
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic Plus
Medinol Paediatric
Medocodene
Melabon Infantil
Mexalen
Midol Maximum Strength
Midol PM Night Time Formula
Midol Regular Strength
Midol Teen Formula
Migraleve Yellow
Minafen
Minoset
Miralgin
Momentum
Mono Praecimed
 
Multin
N-(4-Hydroxyphenyl)acetamide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
N-acetyl-p-aminophenol
NAPA
NCX 701
NEBS
NSC3991
Naldegesic
Napafen
Napap
Naprinol
Nealgyl
Nebs
Neo-Fepramol
NeoCitran
Neodol
Neodolito
Neopap
Neotrend
Neuridon
New Cortal for Children
NilnOcen
Nina
No-Febril
Nobedon
Nodolex
Noral
Norcet
Norco
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/Apap 500
Oxycodone 5/Apap 500
PCM Paracetamol Lichtenstein
Paceco
Pacemo
Pacemol
Pacet
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine Co
Panadiene
Panado-Co
Panado-Co Caplets
Panadol
Panadol Extra Strength
Panadol Junior Strength Caplets
Panadol Maximum Strength Caplets
Panadol Maximum Strength Tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-Deine #3
Papa-Deine #4
Para-Suppo
Para-Tabs
Paracemol
Paracenol
Paracet
Paracetamol
Paracetamol AL
Paracetamol Antipanin P
Paracetamol BC
Paracetamol Basics
Paracetamol DC
Paracetamol Dr. Schmidgall
Paracetamol Fecofar
Paracetamol Genericon
Paracetamol Hanseler
Paracetamol Harkley
Paracetamol Heumann
Paracetamol Hexal
Paracetamol Italfarmaco
Paracetamol Nycomed
Paracetamol PB
Paracetamol Raffo
Paracetamol Ratiopharm
Paracetamol Rosch
Paracetamol Saar
Paracetamol SmithKline Beecham
Paracetamol Stada
Paracetamol Winthrop
Paracetamol von ct
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Paracétamol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
Pe-Tam
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-Demi
Percogesic with Codeine
Perdolan Mono
Perfalgan
Phenaphen
Phenaphen Caplets
Phenaphen W/Codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin Forte
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet World
Redutemp
Reliv
Remedol
Rhinex D-Lay Tablets
Rivalgyl
Robigesic
Robitussin Night Relief
Rockamol Plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
SK-Apap
SPBio_002836
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten Rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sine-Off Sinus Medicine Caplets
Sinedol
Sinmol
Sinubid
Snaplets-FR
Spalt N
Spalt fur die nacht
St Joseph Aspirin-Free
St Joseph Aspirin-Free for Children
St. Joseph Cold Tablets for Children
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed Severe Cold Formula
Sudafed Sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-M
Synalgos-Dc-A
TYL
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol Extra Strength Caplets
Tapanol Extra Strength Tablets
Tapar
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra Caplets
Tempra Chewable Tablets
Tempra D.S
Tempra Drops
Tempra Syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer P
Tralgon
Treupel N
Treupel mon
Treuphadol
Triad
Triaminic Sore Throat Formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
Tylenol
Tylenol (TN)
Tylenol Allergy Sinus
Tylenol Arthritis Extended Relief
Tylenol Caplets
Tylenol Children'S Chewable Tablets
Tylenol Children'S Elixir
Tylenol Children'S Suspension Liquid
Tylenol Drops
Tylenol Elixir
Tylenol Extra Strength Adult Liquid Pain Reliever
Tylenol Extra Strength Caplets
Tylenol Extra Strength Gelcaps
Tylenol Extra Strength Tablets
Tylenol Gelcaps
Tylenol Infants Drops
Tylenol Infants" Suspension Drops
Tylenol Junior Strength Caplets
Tylenol Junior Strength Chewable Tablets
Tylenol Regular Strength Caplets
Tylenol Regular Strength Tablets
Tylenol Tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor Richet
Vicodin
Vicodin Es
Vicodin Hp
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
acetaminofén
acétaminophène
alpha-Per
p-(Acetylamino)phenol
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
p-acetamidophenol
p-acetaminophenol
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-hydroxyphenolacetamide
50
Artesunateapproved18188495-63-06917864, 5464098
Synonyms:
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, hydrogen succinate
112346-66-4
182824-33-5
252637-87-9
4-Oxo-4-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate
4-oxo-4-{[(3r,5as,6r,8as,9r,10r,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
83507-69-1
88495-63-0
91487-94-4
AC1L23PW
AC1L2XWW
AC1L4FU0
AC1Q5VRV
AKOS004119951
AS
Ambap88495-63-0
Arinate
Arsumax
Arsumax (TN)
Artesunate
Artesunate (USAN)
Artesunate (superseded RN)
Artesunato
Artesunato [INN-Spanish]
Artesunatum
Artesunatum [INN-Latin]
Artesunic acid
Artsuna
BB_NC-1045
Butanedioic acid, mono((3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
Butanedioic acid, mono(decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
C19H28O8
CHEMBL218601
CHEMBL258608
CID105031
CID11520210
CID11988384
CID156252
 
CID5464098
CID65664
CID6917864
CID9821433
CPD000466336
D02482
Dihydroartemisinine-12-alpha-succinate
Dihydroqinghaosusuccinate
Dihydroqinghasu hemsuccinate
FT-0082543
HMS2051I14
HMS2090L16
HSDB 7458
I06-0204
LS-177760
LS-187735
MLS000759445
MLS001424053
MolPort-001-732-325
MolPort-006-392-384
NCI60_039350
NSC712571
Nuartez
Plasmotrim
Plasmotrin
Qinghaozhi
Quinghaosu reduced succinate ester
S2265_Selleck
SAM001246628
SM 804
SMR000466336
STK801911
Succinyl dihydroartemisinin
UNII-60W3249T9M
WR 256283
WR-256283
artesunato
artesunatum
artesunic acid
butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester
dihydroqinghasu hemsuccinate

Interventional clinical trials:

(show top 50)    (show all 149)
idNameStatusNCT IDPhase
1Ketotifen as a Treatment for Vascular Leakage During Dengue FeverRecruitingNCT02673840Phase 4
2Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)RecruitingNCT02555072Phase 4
3Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)Unknown statusNCT00966628Phase 3
4Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRUnknown statusNCT00938379Phase 3
5Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in MalaysiaCompletedNCT01254422Phase 3
6Study of a Tetravalent Dengue Vaccine in Healthy Adults in AustraliaCompletedNCT01134263Phase 3
7Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy ToddlersCompletedNCT01411241Phase 3
8Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3
9Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue VaccineRecruitingNCT02406729Phase 3
10Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®RecruitingNCT02979535Phase 3
11Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenRecruitingNCT02747927Phase 3
12Efficacy and Safety of Ivermectin Against Dengue InfectionRecruitingNCT02045069Phase 2, Phase 3
13Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in AsiaActive, not recruitingNCT01373281Phase 3
14Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin AmericaActive, not recruitingNCT01374516Phase 3
15Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy SubjectsNot yet recruitingNCT02992418Phase 3
16Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®Not yet recruitingNCT02993757Phase 3
17The Effect of Chloroquine in the Treatment of Patients With DengueUnknown statusNCT00849602Phase 1, Phase 2
18Chinese and Western Medicine Treatment of Fever Associated With Bleeding SymptomsUnknown statusNCT01973855Phase 2
19A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve ChildrenCompletedNCT00384670Phase 1, Phase 2
20A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive InfantsCompletedNCT00322049Phase 1, Phase 2
21Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in IndiaCompletedNCT01550289Phase 2
22A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesCompletedNCT01064141Phase 2
23Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in SingaporeCompletedNCT00880893Phase 2
24Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South AmericaCompletedNCT01187433Phase 2
25A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00239577Phase 2
26A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive ChildrenCompletedNCT01843621Phase 1, Phase 2
27Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2
28Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue VaccineCompletedNCT01943825Phase 2
29Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCompletedNCT00875524Phase 2
30Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USCompletedNCT00617344Phase 2
31Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCompletedNCT00730288Phase 2
32Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin AmericaCompletedNCT00993447Phase 2
33Efficacy and Safety of Dengue Vaccine in Healthy ChildrenCompletedNCT00842530Phase 2
34Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaCompletedNCT01218906Phase 2
35Study of Febrile Illness for Dengue-Endemic Areas in Latin AmericaCompletedNCT01293331Phase 1, Phase 2
36A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00350337Phase 2
37Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsCompletedNCT00788151Phase 2
38Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)CompletedNCT02193087Phase 2
39Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsCompletedNCT01511250Phase 2
40Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve AdultsCompletedNCT00740155Phase 2
41A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandCompletedNCT00370682Phase 2
42Celgosivir as a Treatment Against DengueCompletedNCT01619969Phase 1, Phase 2
43A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenCompletedNCT00468858Phase 2
44Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic FeverCompletedNCT01601613Phase 2
45The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansCompletedNCT01943305Phase 2
46Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose ScheduleRecruitingNCT02824198Phase 2
47Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, BangladeshRecruitingNCT02678455Phase 2
48Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in ThailandRecruitingNCT02332733Phase 2
49Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsRecruitingNCT02421367Phase 1, Phase 2
50Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose ScheduleActive, not recruitingNCT02623725Phase 2

Search NIH Clinical Center for Dengue Disease


Cochrane evidence based reviews: dengue

Genetic Tests for Dengue Disease

About this section

Anatomical Context for Dengue Disease

About this section

MalaCards organs/tissues related to Dengue Disease:

35
Eye, Skin, Bone, Testes, Endothelial, Thyroid, T cells

Animal Models for Dengue Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Dengue Disease:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.7CCL5, CD40LG, FCGR1A, ICAM1, MBL2, PIK3C2A
2MP:00053876.9CCL5, CD40LG, FCGR1A, ICAM1, MBL2, PIK3C2A

Publications for Dengue Disease

About this section

Articles related to Dengue Disease:

(show top 50)    (show all 86)
idTitleAuthorsYear
1
Clinical and laboratory signs associated to severe dengue disease in hospitalized children. (27112034)
2016
2
Mannose-binding lectin gene (MBL2) polymorphisms related to the mannose-binding lectin low levels are associated to dengue disease severity. (27180198)
2016
3
Relative Contribution of Dengue IgG Antibodies Acquired during Gestation or Breastfeeding in Mediating Dengue Disease Enhancement and Protection in Type I Interferon Receptor-Deficient Mice. (27341339)
2016
4
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease. (27506852)
2016
5
Epidemiological and demographic characteristics of dengue disease at a tertiary care centre in Saurashtra region during the year 2013. (26714509)
2015
6
Biomarkers of severe dengue disease - a review. (26462910)
2015
7
Dengue Disease Risk Mental Models in the City of Dhaka, Bangladesh: Juxtapositions and Gaps Between the Public and Experts. (26387980)
2015
8
Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models. (26001278)
2015
9
Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of CearA!, Brazil. (24626308)
2014
10
Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. (25375162)
2014
11
Dengue disease surveillance: an updated systematic literature review. (24889501)
2014
12
Dengue disease outbreak detection. (25160360)
2014
13
Predictive symptoms and signs of severe dengue disease for patients with dengue fever: a meta-analysis. (25097856)
2014
14
Dengue disease surveillance: improving data for dengue control. (25375232)
2014
15
Epidemiology of dengue disease in malaysia (2000-2012): a systematic literature review. (25375211)
2014
16
Reviewing the literature for epidemiological trends of dengue disease: introduction to a series of seven national systematic literature reviews. (25375830)
2014
17
NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells. (24829565)
2014
18
Epidemiological trends of dengue disease in Thailand (2000-2011): a systematic literature review. (25375766)
2014
19
Dogma in classifying dengue disease. (23926138)
2013
20
Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. (24386496)
2013
21
Atypical presentations of dengue disease in the elderly visiting the ED. (23399333)
2013
22
Can non-human primates serve as models for investigating dengue disease pathogenesis? (24130557)
2013
23
Assessing weather effects on dengue disease in malaysia. (24287855)
2013
24
Spatial distribution of dengue disease in municipality of MossorA^, Rio Grande do Norte, using the Geographic Information System. (24896274)
2013
25
Environmental influences on antibody-enhanced dengue disease outcomes. (23295753)
2012
26
Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity. (21995849)
2012
27
Evaluation of the traditional and revised WHO classifications of Dengue disease severity. (22087348)
2011
28
Characterization of early host responses in adults with dengue disease. (21810247)
2011
29
Influence of environmental conditions on asynchronous outbreaks of dengue disease and increasing vector population in Kaohsiung, Taiwan. (21424970)
2011
30
Dengue disease status in Chennai (2006-2008): a retrospective analysis. (21441688)
2011
31
Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. (22190239)
2011
32
Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity. (20858223)
2011
33
A BALB/c mouse model shows that liver involvement in dengue disease is immune-mediated. (20673760)
2010
34
Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. (20153282)
2010
35
Stochastic eco-epidemiological model of dengue disease transmission by Aedes aegypti mosquito. (19861133)
2010
36
Dengue disease. (20954580)
2010
37
Markers of dengue disease severity. (19802579)
2010
38
Characteristic of dengue disease in Taiwan: 2002-2007. (20348527)
2010
39
Understanding the contribution of cellular immunity to dengue disease pathogenesis. (18837790)
2008
40
Describing the geographic spread of dengue disease by traveling waves. (18590749)
2008
41
Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system. (17386105)
2007
42
Blood group AB is associated with increased risk for severe dengue disease in secondary infections. (17330792)
2007
43
NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. (16412060)
2006
44
Relationship of thrombopoietin and interleukin-11 levels to thrombocytopenia associated with dengue disease. (16759877)
2006
45
Genetic variations and relationship among dengue virus type 3 strains isolated from patients with mild or severe form of dengue disease in Indonesia and Thailand. (16438144)
2005
46
Virological interpretations of dengue disease spectrum in infants in Chennai, Tamil Nadu, India, need reevaluation. (15131236)
2004
47
Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. (12641411)
2003
48
Dengue disease spectrum among infants in the 2001 dengue epidemic in Chennai, Tamil Nadu, India. (12904418)
2003
49
Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. (1951875)
1991
50
RECENT EPIDEMICS OF HEMORRHAGIC FEVER IN THAILAND. OBSERVATIONS RELATED TO PATHOGENESIS OF A "NEW" DENGUE DISEASE. (14334760)
1965

Variations for Dengue Disease

About this section

Expression for genes affiliated with Dengue Disease

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Dengue Disease patients vs. healthy controls: 34 (show all 93)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1IFI27interferon, alpha-inducible protein 27Blood+4.850.000
2RRM2ribonucleotide reductase M2Blood+4.480.000
3CEP55centrosomal protein 55kDaBlood+4.330.000
4BIRC5baculoviral IAP repeat containing 5Blood+4.300.000
5XISTX inactive specific transcript (non-protein coding)Blood-4.250.009
6CD38CD38 moleculeBlood+4.230.000
7DLGAP5discs, large (Drosophila) homolog-associated protein 5Blood+4.100.000
8BUB1BUB1 mitotic checkpoint serine/threonine kinaseBlood+4.080.000
9IGHMimmunoglobulin heavy constant muBlood+4.040.000
10MCM10minichromosome maintenance 10 replication initiation factorBlood+3.990.000
11SHCBP1SHC SH2-domain binding protein 1Blood+3.970.000
12PBKPDZ binding kinaseBlood+3.970.000
13TYMSthymidylate synthetaseBlood+3.960.000
14PI3peptidase inhibitor 3, skin-derivedBlood-3.930.000
15CDCA2cell division cycle associated 2Blood+3.910.000
16SESN3sestrin 3Blood-3.900.000
17HMMRhyaluronan-mediated motility receptor (RHAMM)Blood+3.830.000
18MKI67marker of proliferation Ki-67Blood+3.830.000
19ZWINTZW10 interacting kinetochore proteinBlood+3.830.000
20DTLdenticleless E3 ubiquitin protein ligase homolog (Drosophila)Blood+3.800.000
21CDK1cyclin-dependent kinase 1Blood+3.780.000
22NCAPGnon-SMC condensin I complex, subunit GBlood+3.760.000
23CDT1chromatin licensing and DNA replication factor 1Blood+3.760.000
24SPC25SPC25, NDC80 kinetochore complex componentBlood+3.750.000
25CDC20cell division cycle 20Blood+3.730.000
26CNTNAP3contactin associated protein-like 3Blood-3.720.000
27TOP2Atopoisomerase (DNA) II alphaBlood+3.710.000
28NOVnephroblastoma overexpressedBlood-3.710.000
29EIF1AYeukaryotic translation initiation factor 1A, Y-linkedBlood+3.690.015
30CCNB2cyclin B2Blood+3.620.000
31CDKN3cyclin-dependent kinase inhibitor 3Blood+3.620.000
32KIAA0101KIAA0101Blood+3.610.000
33KIF2Ckinesin family member 2CBlood+3.600.000
34TK1thymidine kinase 1, solubleBlood+3.590.000
35RPS4Y1ribosomal protein S4, Y-linked 1Blood+3.570.017
36TTKTTK protein kinaseBlood+3.560.000
37CDC6cell division cycle 6Blood+3.560.000
38CAV1caveolin 1, caveolae protein, 22kDaBlood+3.560.000
39CENPAcentromere protein ABlood+3.540.000
40CYAT1immunoglobulin lambda light chain-likeBlood+3.520.000
41ASPMabnormal spindle microtubule assemblyBlood+3.520.000
42OR2W3olfactory receptor, family 2, subfamily W, member 3Blood-3.510.000
43UHRF1ubiquitin-like with PHD and ring finger domains 1Blood+3.500.000
44SELENBP1selenium binding protein 1Blood-3.500.000
45GINS2GINS complex subunit 2 (Psf2 homolog)Blood+3.490.000
46MELKmaternal embryonic leucine zipper kinaseBlood+3.470.000
47BUB1BBUB1 mitotic checkpoint serine/threonine kinase BBlood+3.470.000
48CHEK1checkpoint kinase 1Blood+3.460.000
49CCNB1cyclin B1Blood+3.450.000
50KIF11kinesin family member 11Blood+3.420.000
51E2F8E2F transcription factor 8Blood+3.410.000
52CCNA2cyclin A2Blood+3.400.000
53KCTD14potassium channel tetramerization domain containing 14Blood+3.400.000
54IGLimmunoglobulin lambda locusBlood+3.370.000
55IGLJ3immunoglobulin lambda joining 3Blood+3.350.000
56CDCA5cell division cycle associated 5Blood+3.310.000
57TPX2TPX2, microtubule-associatedBlood+3.310.000
58KIF20Akinesin family member 20ABlood+3.300.000
59E2F7E2F transcription factor 7Blood+3.280.000
60ANLNanillin actin binding proteinBlood+3.280.000
61KDM5Dlysine (K)-specific demethylase 5DBlood+3.280.017
62JAZF1JAZF zinc finger 1Blood-3.270.000
63HJURPHolliday junction recognition proteinBlood+3.250.000
64IGKV3-20immunoglobulin kappa variable 3-20Blood+3.240.000
65KIF4Akinesin family member 4ABlood+3.220.000
66KIF15kinesin family member 15Blood+3.200.000
67CNTNAP3Bcontactin associated protein-like 3BBlood-3.190.000
68TNFRSF17tumor necrosis factor receptor superfamily, member 17Blood+3.190.000
69AURKBaurora kinase BBlood+3.180.000
70TRIP13thyroid hormone receptor interactor 13Blood+3.180.000
71CCND2cyclin D2Blood+3.170.000
72GINS1GINS complex subunit 1 (Psf1 homolog)Blood+3.160.000
73IGLV2-23immunoglobulin lambda variable 2-23Blood+3.150.000
74SLC6A8solute carrier family 6 (neurotransmitter transporter), member 8Blood-3.150.000
75KIF18Bkinesin family member 18BBlood+3.140.000
76OIP5Opa interacting protein 5Blood+3.140.000
77KRT1keratin 1, type IIBlood-3.120.001
78GGHgamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)Blood+3.110.000
79RAD51RAD51 recombinaseBlood+3.100.000
80GLDCglycine dehydrogenase (decarboxylating)Blood+3.100.000
81RAD51AP1RAD51 associated protein 1Blood+3.090.000
82DDX3YDEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linkedBlood+3.090.028
83MBNL3muscleblind-like splicing regulator 3Blood-3.090.000
84IGLV1-44immunoglobulin lambda variable 1-44Blood+3.090.000
85MCM4minichromosome maintenance complex component 4Blood+3.080.000
86IGLV4-60immunoglobulin lambda variable 4-60Blood+3.080.000
87FOXM1forkhead box M1Blood+3.060.000
88ESPL1extra spindle pole bodies like 1, separaseBlood+3.060.000
89SLC4A1solute carrier family 4 (anion exchanger), member 1 (Diego blood group)Blood-3.050.000
90IGLV3-19immunoglobulin lambda variable 3-19Blood+3.040.000
91GTSE1G-2 and S-phase expressed 1Blood+3.040.000
92PDZK1IP1PDZK1 interacting protein 1Blood-3.020.000
93USP18ubiquitin specific peptidase 18Blood+3.000.000

Search GEO for disease gene expression data for Dengue Disease.

Pathways for genes affiliated with Dengue Disease

About this section

Pathways related to Dengue Disease according to GeneCards Suite gene sharing:

(show all 20)
idSuper pathwaysScoreTop Affiliating Genes
110.0ICAM1, VCAM1
29.9CD209, RAF1
39.8CD40LG, ICAM1, VCAM1
49.8CD40LG, ICAM1, VCAM1
59.8CD40LG, ICAM1, VCAM1
69.8CD40LG, ICAM1, VCAM1
79.7CCL5, ICAM1, VCAM1
89.5FCGR1A, ICAM1, MBL2
99.5CD209, IL11, THPO
109.4IL11, THPO, VCAM1
119.4CCL5, ICAM1, IL11
129.3CD40LG, FCGR1A, ICAM1, VCAM1
139.3FCGR1A, IL11, THPO
149.3ICAM1, PTPN11, RAF1, VCAM1
15
Show member pathways
9.3ICAM1, PTPN11, RAF1, VCAM1
16
Show member pathways
9.2FCGR1A, ICAM1, PTPN11, VCAM1
179.0ICAM1, IL11, PTPN11, RAF1
18
Show member pathways
8.8CCL5, ICAM1, IL11, PTPN11, THPO
19
Show member pathways
8.0CCL5, CD209, HCFC1, ICAM1, IVNS1ABP, PTPN11
20
Show member pathways
7.6CD209, CD40LG, FCGR1A, ICAM1, IL11, MBL2

GO Terms for genes affiliated with Dengue Disease

About this section

Cellular components related to Dengue Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell surfaceGO:00099868.9CD209, CD40LG, ICAM1, MBL2, VCAM1
2extracellular spaceGO:00056158.4CCL5, CD40LG, ICAM1, IL11, MBL2, THPO

Biological processes related to Dengue Disease according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1membrane to membrane dockingGO:002261410.6ICAM1, VCAM1
2chronic inflammatory responseGO:000254410.3CCL5, VCAM1
3negative regulation of hormone secretionGO:004688810.2IL11, PTPN11
4heterophilic cell-cell adhesion via plasma membrane cell adhesion moleculesGO:000715710.1CD209, ICAM1, VCAM1
5neurotrophin TRK receptor signaling pathwayGO:004801110.1PTPN11, RAF1
6regulation of protein complex assemblyGO:004325410.0HCFC1, PTPN11
7interferon-gamma-mediated signaling pathwayGO:006033310.0FCGR1A, ICAM1, VCAM1
8cellular response to tumor necrosis factorGO:007135610.0CCL5, ICAM1, VCAM1
9positive regulation of T cell proliferationGO:00421029.9CCL5, CD40LG, VCAM1
10B cell differentiationGO:00301839.8CD40LG, IL11, VCAM1
11leukocyte cell-cell adhesionGO:00071599.7CCL5, CD209, CD40LG, ICAM1, VCAM1
12regulation of immune responseGO:00507769.6CD40LG, FCGR1A, ICAM1, VCAM1
13platelet activationGO:00301689.4CD40LG, PTPN11, RAF1
14positive regulation of ERK1 and ERK2 cascadeGO:00703749.3CCL5, ICAM1, PTPN11, THPO

Molecular functions related to Dengue Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mannose bindingGO:000553710.0CD209, MBL2

Sources for Dengue Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet